Levels of Evidence Needed for Changing Indications, Contraindications, and Food and Drug Administration Labeling: The Case of Metformin
Eurich DT, Majumdar SR, McAlister FA, Tsuyuki RT, Johnson JA.
Arch Intern Med. 2011;171(11):1042-1043.
Published online June 13, 2011
Select Pricing Criteria:
Choose criteria for pricing info
Want online access for an institution? Learn More/Request Quote >